Tag Archives: submission
Amylin, Lilly and Alkermes Complete receive the response letter from FDA for exenatide once weekly submission
Amylin, Lilly and Alkermes Receive Complete Response Letter from FDA for exenatide Once Weekly Submission
SAN DIEGO & INDIANAPOLIS & WALTHAM, Mass.—-Amylin Pharmaceuticals, Inc. , Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON™ .
Read more [...]
Amylin, Lilly and Alkermes will receive the complete response letter from FDA for exenatide once weekly submission
Amylin, Lilly And Alkermes Receive Complete Response Letter From FDA For Exenatide Once Weekly Submission
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON™ (exenatide for [...]